CDK2-IN-13-d3
CDK2-IN-13-d3 is the deuterium labeled CDK2-IN-13 (HY-W478102) . CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 μM. CDK2-IN-13 can be used in research of cancer[1].
Product Specifications
UNSPSC
12352005
Target
CDK; Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
ClC1=NC(N(C([2H])([2H])[2H])C=N2)=C2C(NCC3=CC=CC=C3)=N1
Molecular Formula
C13H9D3ClN5
Molecular Weight
276.74
References & Citations
[1]Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40 (4) :408-12.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6496926-01 0.1 mL
Raptor, Phosphorylated (Ser863) (Regulatory-associated Protein of mTOR, Raptor, P150 Target of Rapamycin (TOR)-scaffold Protein, RPTOR, KIAA1303) (MaxLight 490)
Ask
View Details 
MBS6496926-02 5x 0.1 mL
Raptor, Phosphorylated (Ser863) (Regulatory-associated Protein of mTOR, Raptor, P150 Target of Rapamycin (TOR)-scaffold Protein, RPTOR, KIAA1303) (MaxLight 490)
Ask
View Details 
abx311856-01 20 µg
SAM Domain, SH3 Domain And Nuclear Localization Signals 1 (SAMSN1) Antibody
Ask
View Details abx311856-02 50 µg
SAM Domain, SH3 Domain And Nuclear Localization Signals 1 (SAMSN1) Antibody
Ask
View Details abx311856-03 100 µg
SAM Domain, SH3 Domain And Nuclear Localization Signals 1 (SAMSN1) Antibody
Ask
View Details